GH1 and colorectal cancer: Combining recombinant GH with radiation increases clonogenic survival and reduces DNA damage in a colorectal cancer cell line (Wu et al., 2014), whereas the over-expression of GHR in rectal cancer is predictive factor for tumor response to preoperative radiotherapy (Wu et al., 2006).